1109969

Stason Pharmaceuticals, Inc. — FEI 1000160561

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 25, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)